Metraipolis › archive › dc_8c4e98315aed
Comparative Long-Term Cardiovascular Outcomes of Empagliflozin and Dapagliflozin in Heart Failure Patients After Coronary Revascularization: A Retrospective… — Europe PMC PMID:41375685
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41375685
- DOI
- 10.3390/jcm14238383
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T05:50:39.647Z
- SHA-256 of the archived text
e73c78602f44dbc5fc81f99eed6b95b8d8eac7462947c06f0fc491cc2d3227b9- Stable URL of this page
https://metraipolis.com/documento/dc_8c4e98315aed
How to cite
Comparative Long-Term Cardiovascular Outcomes of Empagliflozin and Dapagliflozin in Heart Failure Patients After Coronary Revascularization: A Retrospective… — Europe PMC PMID:41375685 — Europe PMC (en), https://europepmc.org/article/MED/41375685 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8c4e98315aed (Metraipolis archive dc_8c4e98315aed, sha256 e73c78602f44dbc5fc81f99eed6b95b8d8eac7462947c06f0fc491cc2d3227b9)
BibTeX
@misc{dc8c4e98315aed,
title = {Comparative Long-Term Cardiovascular Outcomes of Empagliflozin and Dapagliflozin in Heart Failure Patients After Coronary Revascularization: A Retrospective… — Europe PMC PMID:41375685},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41375685},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8c4e98315aed; sha256 e73c78602f44dbc5fc81f99eed6b95b8d8eac7462947c06f0fc491cc2d3227b9},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41375685. Agents can read the archived copy with the MCP tool read_document.